CN103146595B - Bacillus subtilis and method for fermentation production of D- ribose - Google Patents
Bacillus subtilis and method for fermentation production of D- ribose Download PDFInfo
- Publication number
- CN103146595B CN103146595B CN201210505600.4A CN201210505600A CN103146595B CN 103146595 B CN103146595 B CN 103146595B CN 201210505600 A CN201210505600 A CN 201210505600A CN 103146595 B CN103146595 B CN 103146595B
- Authority
- CN
- China
- Prior art keywords
- ribose
- fermentation
- bacterial strain
- subtilis
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title claims abstract description 129
- 238000000855 fermentation Methods 0.000 title claims abstract description 35
- 230000004151 fermentation Effects 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 30
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 63
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000007788 liquid Substances 0.000 claims abstract description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 33
- 239000008103 glucose Substances 0.000 claims abstract description 32
- 230000001580 bacterial effect Effects 0.000 claims abstract description 27
- 240000008042 Zea mays Species 0.000 claims abstract description 19
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 19
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 19
- 235000005822 corn Nutrition 0.000 claims abstract description 19
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 239000002609 medium Substances 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 18
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 16
- 239000001963 growth medium Substances 0.000 claims description 14
- 238000011218 seed culture Methods 0.000 claims description 14
- 239000013028 medium composition Substances 0.000 claims description 12
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 7
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 239000008272 agar Substances 0.000 claims description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 7
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 7
- 238000012262 fermentative production Methods 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- QLULGSLAHXLKSR-UHFFFAOYSA-N azane;phosphane Chemical compound N.P QLULGSLAHXLKSR-UHFFFAOYSA-N 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 101900069548 Bacillus subtilis Transketolase Proteins 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 238000009629 microbiological culture Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 102000014701 Transketolase Human genes 0.000 description 16
- 108010043652 Transketolase Proteins 0.000 description 16
- 230000002950 deficient Effects 0.000 description 16
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 14
- 241000726221 Gemma Species 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 241000194103 Bacillus pumilus Species 0.000 description 5
- -1 Hexose phosphate Chemical class 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000000153 supplemental effect Effects 0.000 description 5
- 101710088194 Dehydrogenase Proteins 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
- 241001494627 Eucalyptus subtilis Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002962 chemical mutagen Substances 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000219 mutagenic Toxicity 0.000 description 3
- 230000003505 mutagenic effect Effects 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 206010010254 Concussion Diseases 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 238000010564 aerobic fermentation Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001320 aldopentoses Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 108091006091 regulatory enzymes Proteins 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a bacillus subtilis BAV20120416 bacterial strain and a method for fermentation production of a D- ribose by the bacterial strain. The bacterial strain is preserved in China General Microbiological Culture Collection Center (CGMCC) on April, 16th in 2012. The preservation number of the bacterial strain is CGMCC NO.6013. The bacterial strain is a bacillus subtilis transketolase deletion mutation strain, has the advantages that hereditary stability is good, spores are difficult to generate and the like, and is capable of accumulating more than 90g/L of the D-ribose in a fermentation medium with glucose and corn steep liquor as main raw materials. The D-ribose accumulated by the bacterial strain is about third more than that accumulated by a parent strain of the bacterial strain, wherein the parent strain is bacillus subtilis ATCC21360. The fermentation time is short and generally controlled to be about 50 hours which is one-third lower than the time in the prior art. Particularly, impurities are few. Residual sugar of final fermentation liquid is reduced to 0. The bacterial strain is particularly applicable to the requirements for medicine production.
Description
Technical field
The invention belongs to technical field of microbial fermentation, be specifically related to a kind of subtilis and the method with this bacterium fermentative production D-ribose.
Background technology
D-ribose is a kind of epochmaking aldopentose, is the important composition composition of genetic material nucleic acid in organism, is also the important intermediate metabolites of organism composite part amino acid, base etc., has important physiological function.
D-ribose is used to semi-synthesis method at first and produces vitamins B
2.Along with carrying out in a deep going way of D-ribose industrial expansion and applied research thereof, its prospect in foodstuffs industry and medicine industry etc. is also realized gradually, and D-ribose can as raw materials for production synthetic nucleosides acids flavour enhancer, as 5 '-IMP, 5 '-GMP etc.; On medicine industry, it is antiviral as synthesis, the investigation and application of the bulk drug of cancer therapy drug is also more and more extensive.D-ribose is as the natural components be present in all cells simultaneously, close relationship is had with the formation of adenylic acid (AMP) and the regeneration of ATP, it is one of the most basic energy derive of vital metabolic, play a crucial role in heart and muscle metabolism, the recovery of local organization ischemic, anoxic can being promoted, at treatment myocardial ischaemia, preventing and treating because also there is good action in kinetic sore muscle and antifatigue.In a word, D-ribose has boundless application prospect.
Since going out D-ribose from late nineteenth century human identification, the production method of D-ribose mainly experienced by enzymatic hydrolysis RNA, with other sugar or organic acid for raw material chemosynthesis with utilize fermentable to produce three classes.Wherein, the procedure of enzymatic hydrolysis RNA separating D-ribose is numerous and diverse, manufacturing cost is high, yield is low, is not suitable for carrying out scale operation; Because the technological process of mercury electrode point solution can be used in chemical synthesis production process, easily cause serious environmental pollution.Enter the seventies in last century, people start with metabolic control fermentation theoretical for instructing, and utilize microbial nutrition deficient strain to carry out the research of D-Ribose by Fermentation.Sasajima found in the research of 1971 subtilis transketolase deficient type bacterial strain with 12.5% glucose for during carbon source through 6 days fermentation, in final fermented liquid, the accumulation volume of D-ribose is 35g/L; Within 1976, carry out aerobic fermentation with the subtilis after improvement and bacillus pumilus transketolase deficient mutant strain, the accumulation volume of D-ribose reaches 72.3g/L.The bacillus pumilus transketolase deficient mutant strain such as Kishimoto in 1988, in the substratum adding die aromatischen Aminosaeuren, the output of D-ribose reaches 92.1 g/L.Within 1997, Wulf bacillus pumilus transketolase deficient mutant strain produces D-ribose, and its productive rate is 45 g/L.Within 1997, the bright subtilis transketolase deficient mutant strain waiting seed selection of Jiangsu institute of microbiology Deng Chong is that substrate carries out aerobic fermentation with glucose, and D-ribose output is up to 92 g/L.
Research through above-mentioned investigators finds that subtilis and bacillus pumilus transketolase deficient mutant strain can accumulate D-ribose in a large number.In addition, by research D-ribose biosynthesizing and relevant metabolic pathway known, the carrying out that microorganism accumulates D-ribose in a large number except blocking its downstream metabolic approach being made, also should increase the synthesis of D-ribose precursor, namely increase the vigor of Hexose phosphate dehydrogenase.Hexose phosphate dehydrogenase is the regulatory enzyme of this biosynthetic pathway, irreversible reaction, and the size of its vigor determines D-ribose output height.In genus bacillus, Hexose phosphate dehydrogenase is relevant with the formation of gemma, is induced to produce in sporulation process.But the formation of gemma can change kind and the quantity of microbe endoenzyme, affects its normal metabolic activity, is unfavorable for the accumulation of D-ribose.The D-ribose superior strain obtained is separated from subtilis, the synthesis of Hexose phosphate dehydrogenase is not suppressed, can independently be present in nourishing body cell, the research of Sasajima also confirms this point, he produces bacterial strain to D-ribose and carries out mutagenesis repeatedly, when maintaining transketolase disappearance, select the mutant strain of a strain glucose dehydro enzyme activity height and the forfeiture of gemma generative capacity, D-ribose output reaches 70 g/L.
In above-mentioned domestic and international report, D-ribose fermentation is carried out by seed selection subtilis or bacillus pumilus transketolase deficient mutant strain, the output of D-ribose reaches a higher level, but also there is the shortcoming that residual sugar is high, fermented liquid impurity is many, be unfavorable for the subsequent extracted of D-ribose; Fermenting process easily generates gemma, affects the output of D-ribose; Fermentation period is long, is generally greater than 70 hours.
Summary of the invention
The object of the present invention is to provide a kind of subtilis lost gemma generative capacity, stablize high yield D-ribose, and this strain fermentation produces the method for D-ribose, to overcome the defect that prior art residual sugar is high, easily produce gemma, fermentation period length.
Bacterial strain provided by the present invention be subtilis (
bacillussubtilis) BAV20120416, so that the strains A TCC21360 of D-ribose can be accumulated on a small quantity for starting strain purchased from a strain of Beijing North Na Chuanlian Bioteknologisk Institut, adopt routine mutagenesis method, the physics such as ultraviolet, nitrosoguanidine, chemical mutagen process are carried out to ATCC21360, through repeatedly repeatedly mutagenesis screening to cultivate, final fermented liquid residual sugar can be made to reduce to 0, other impurity are few, fermenting process not easily produces gemma, fermentation period is short, and can stablize the bacterial strain carrying out D-ribose suitability for industrialized production.
Subtilis of the present invention (
bacillussubtilis) BAV20120416 bacterial strain, on April 16th, 2012 in the center preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms, preserving number is: CGMCC NO.6013, and preservation address is: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City Institute of Microorganism, Academia Sinica.
One, the acquisition of subtilis BAV20120416
With subtilis ATCC21360 for initial strain, on slant medium, cultivate 1 ~ 2 day under 32 ~ 38 DEG C of conditions, scraping somatic cells, in stroke-physiological saline solution, makes bacteria suspension, makes cell concn be 1 × 10
8~ 10
9individual/mL.Conveniently mutafacient system, with the physics such as ultraviolet lamp, nitrosoguanidine, chemical mutagen is alternate or process continuously.Get above-mentioned bacteria suspension in culture dish, under being placed in 15W ultraviolet lamp, distance 20cm, irradiates 0.5 ~ 5 minute; Get the nitrosoguanidine treatment solution of above-mentioned bacteria suspension 1mg/mL, 32 ~ 38 DEG C of insulation concussions 30 ~ 60 minutes, by centrifugal for the thalline of nitrosoguanidine process, with normal saline flushing several times, to remove residual nitrosoguanidine.Or the continuous bacterium liquid that processed alternate with ultraviolet lamp, nitrosoguanidine are coated on plate culture medium, cultivate 1 ~ 2 day under 32 ~ 38 DEG C of conditions, get single bacterium colony to put respectively on minimum medium and supplemental medium, screening well-grown on supplemental medium, and the bacterium colony that can not grow on minimum medium, i.e. subtilis transketolase deficient type bacterial strain.The bacterial strain of screening is sieved and further separation screening again through seed culture medium and fermention medium shake flask fermentation, select a strain stable hereditary property, not easily sprout that spore, fermentation period are short, the bacterial strain of high yield D-ribose, be subtilis transketolase deficient mutant strain that preserving number is CGMCC NO.6013 (
bacillussubtilis) BAV20120416.
Above-mentioned subtilis BAV20120416 biological property: cell size 0.7 ~ 0.8 × 2 ~ 3 microns, in rod-short, Dan Sheng, in pairs or in catenation, without pod membrane, can motion, bacterium colony is circular or irregular, and bacterium colony is flat, surface irregularity is opaque, dirty white or micro-yellow.Physio-biochemical characteristics: Gram-positive, aerobic, chemoheterotrophy, liquefy gelatin, peptonized milk, reduction nitrate, catalase is positive, can assimilate carbohydrate (glucose, sorbyl alcohol, Zulkovsky starch, N.F,USP MANNITOL, fructose etc.), can utilize nitrogenous source (ammonium sulfate, yeast powder, extractum carnis, peptone, corn steep liquor etc.), growth pH 5 ~ 8, growth temperature 32 ~ 38 DEG C.
Two, the method for novel bacterial BAV20120416 fermentative production D-ribose
1, slant culture
Above-mentioned mutagenic obtained subtilis transketolase deficient mutant strain BAV20120416 is inoculated in slant medium, cultivates 1 ~ 2 day for 32 ~ 38 DEG C, obtained slant strains.
2, seed culture
Get slant strains and be inoculated in seed culture medium 32 ~ 38 DEG C of shaking tables cultivation 12 ~ 16h, obtained fermentation kind of a daughter bacteria liquid, OD value 1.2-1.5.
3, fermentation culture
By 5% ~ 10%(by volume %) inoculum size seed liquor is accessed in preprepared fermention medium, fermentation culture is carried out under 32 ~ 38 DEG C of conditions, fermentation time 40 ~ 60h, the initial pH 6.5 ~ 7.2 of fermented liquid, adding soda acid by stream in fermenting process makes fermented liquid pH control 5.6 ~ 7.0, timing sampling in fermenting process, observe growth state, measure the concentration of glucose and D-ribose in fermented liquid, when in fermented liquid, glucose concn drops to 0, maintain for some time, when D-ribose concentration no longer rises, fermentation ends.
Above-mentioned slant medium composition (%): peptone 0.5 ~ 2.0, corn steep liquor 0.5 ~ 1.0, yeast powder 0.5 ~ 1.0, sodium-chlor 0.2 ~ 0.5, manganous sulfate 0.005 ~ 0.01, agar 1.2 ~ 2.0, regulates pH 6.5 ~ 7.2.
Above-mentioned seed culture medium composition (%): glucose 1.0 ~ 3.0, corn steep liquor 0.5 ~ 1.0, dipotassium hydrogen phosphate 0.2 ~ 0.5, potassium primary phosphate 0.05 ~ 0.2, manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2.
Above-mentioned fermention medium composition (%): glucose 12.0 ~ 20.0, corn steep liquor 1.0 ~ 3.0, ammonium sulfate 0.3 ~ 1.0, phosphorus ammonium 0.2 ~ 1.0, manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2.
The measuring method of glucose in above-mentioned fermented liquid: use the SBA-40D type bio-sensing analyser that Shandong Province academy sciences Biology Research Institute produces, by glucose content in the mensuration fermented liquid that immobilized glucose oxidase film is single-minded.
D-Glucose+H
2o
glucose oxidase maltonic acid+H
2o
2
The measuring method of above-mentioned D-ribose: adopt Dionex U3000 liquid chromatographic system to measure the content of D-ribose in fermented liquid, actual conditions is as follows:
Pump: Dionex U3000 Pump
Post: Kromasil 100-5NH2 (200 × 4.6mm)
Moving phase: acetonitrile: water=70:30(V:V)
Flow velocity: 1.0ml/mL
Column temperature: 40 DEG C
Detector: Shodex RI-101 Composition distribution
BAV20120416 of the present invention and parental plant ATCC21360 glucose fermentation comparing result are in table 1:
As can be seen from above-mentioned comparing result, the D-ribose superior strain BAV20120416 that the present invention obtains is subtilis transketolase-deficient mutant, have genetic stability good, not easily produce the feature such as gemma; More than 90g/L D-ribose can be accumulated in the fermention medium being main raw material with glucose, corn steep liquor, be about three times of its parental plant subtilis ATCC21360, fermentation period is short, general control is at 50 hours, lower than prior art about 1/3, particularly impurity is few, final fermented liquid residual sugar reduces to 0(glucose and ribulose residual quantity by existing testing method, all do not detect), be specially adapted to medical production requirement, more existing bacterial classification has greater advantage, is the strain excellent with industrial applications potentiality; And adopt the ribose that existing strain fermentation is produced, the wherein residual sugar impurity of about residual 1%, do not reach the requirement of medical production standard.
Accompanying drawing explanation
Fig. 1 represents the liquid chromatogram of bacterial strain of the present invention final fermented liquid D-ribose assay
Fig. 2 represents the liquid chromatogram of existing parental plant final fermented liquid D-ribose assay
(note: sample is sample introduction after dilution 5 times)
As seen from Figure 1, in the final fermented liquid of bacterial strain BAV20120416 of the present invention, desolventize outside peak, only have a D-ribose peak, the sample size of D-ribose is 0.0189 × 5g/ml, i.e. 94.5g/L.As seen from Figure 2, in the final fermented liquid of existing parental plant ATCC21360, desolventize peak, D-ribose peak, also have glucose peaks and ribulose peak, the sample size of D-ribose is 0.0067 × 5g/ml, i.e. 33.5 g/L; The sample size of glucose is 0.0010 × 5g/ml, i.e. 5g/L, that is there is residual sugar in final fermented liquid; Also have a ribulose peak in addition, illustrate and create other impurity at the fermenting process of existing parental plant ATCC21360.
Embodiment
embodiment 1
By subtilis ATCC21360 on slant medium, cultivate 2 days under 35 ~ 38 DEG C of conditions, scraping somatic cells, in stroke-physiological saline solution, makes bacteria suspension, be cell concn is 1 × 10
8~ 10
9individual/mL.Conveniently mutafacient system, with the physics such as ultraviolet lamp, nitrosoguanidine, chemical mutagen is alternate or process continuously.Get above-mentioned bacteria suspension in culture dish, under being placed in 15W ultraviolet lamp, distance 20cm, irradiates 0.5 ~ 5 minute; Get the nitrosoguanidine treatment solution of above-mentioned bacteria suspension 1mg/mL, 35 ~ 38 DEG C of insulation concussions 30 ~ 60 minutes, by centrifugal for the thalline of nitrosoguanidine process, with normal saline flushing several times, to remove residual nitrosoguanidine.By alternate with ultraviolet lamp, nitrosoguanidine or the continuous bacterium liquid coating processed with on plate culture medium, cultivate 1 ~ 2 day under 35 ~ 38 DEG C of conditions, get single bacterium colony to put respectively on minimum medium and supplemental medium, screening well-grown on supplemental medium, and the bacterium colony that can not grow on minimum medium, i.e. subtilis transketolase deficient type bacterial strain.The bacterial strain of screening is sieved and further separation screening again through seed culture medium and fermention medium shake flask fermentation, select a strain stable hereditary property, not easily sprout that spore, fermentation period are short, the bacterial strain of high yield D-ribose, i.e. subtilis transketolase deficient mutant strain BAV20120416.
Above-mentioned nitrosoguanidine treatment solution preparation: take 10mg nitrosoguanidine in brown bottle, add 1mL acetone and make it dissolve, then add water 10mL, be made into the nitrosoguanidine treatment solution of 1mg/mL.
Above-mentioned slant medium composition (%): peptone 0.5 ~ 2.0, corn steep liquor 0.5 ~ 1.0, yeast powder 0.5 ~ 1.0, sodium-chlor 0.2 ~ 0.5, manganous sulfate 0.005 ~ 0.01, agar 1.2 ~ 2.0, regulates pH 6.5 ~ 7.2.
Above-mentioned plate culture medium composition (%): peptone 0.5 ~ 2.0, Dried Corn Steep Liquor Powder 0.5 ~ 1.0, yeast powder 0.5 ~ 1.0, sodium-chlor 0.2 ~ 0.5, manganous sulfate 0.005 ~ 0.01, agar 1.2 ~ 2.0, regulates pH 6.5 ~ 7.2.
Above-mentioned minimum medium composition (%): glucose 0.5 ~ 1.0, ammonium sulfate 0.1 ~ 0.3, dipotassium hydrogen phosphate 0.5 ~ 1.5, potassium primary phosphate 0.3 ~ 0.8, magnesium sulfate 0.01 ~ 0.04, manganous sulfate 0.001 ~ 0.01, agar 1.2 ~ 2.0, regulates pH 6.5 ~ 7.2.
Above-mentioned supplemental medium composition (%): the shikimic acid adding 40 ~ 60mg/mL in minimum medium.
Above-mentioned seed culture medium composition (%): glucose 1.0 ~ 3.0, corn steep liquor 0.5 ~ 1.0, dipotassium hydrogen phosphate 0.2 ~ 0.5, potassium primary phosphate 0.05 ~ 0.2, manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2.
Above-mentioned fermention medium composition (%): glucose 14.0 ~ 20.0, corn steep liquor 1.0 ~ 3.0, ammonium sulfate 0.3 ~ 1.0, phosphorus ammonium 0.2 ~ 1.0, manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2.
embodiment 2
Mutagenic obtained subtilis transketolase deficient mutant strain BAV20120416 is inoculated in slant medium, cultivates 2 days for 36 DEG C, obtained slant strains.Get a ring slant strains to be inoculated in and to be equipped with in the 500mL triangular flask of 50mL seed culture medium, 36 DEG C, 14h cultivated by 150 r/min shaking tables, inoculum size access by 10% is preprepared is equipped with in the 5L shaking flask of 500mL fermention medium, at 36 DEG C, rotating speed 150r/min carries out shaker fermentation cultivation, ferments after 48 hours, in fermented liquid, glucose content drops to 0 after measured, and D-ribose content reaches 90.2g/L; And its parental plant ATCC21360 under the same conditions, need cultivate 72 hours, and in fermented liquid, glucose content no longer declines after dropping to 4 g/L, in fermented liquid, D-ribose content is only 29.7g/L.
Above-mentioned slant medium composition (%): peptone 1.0, corn steep liquor 0.5, yeast powder 0.5, sodium-chlor 0.5, manganous sulfate 0.005, agar 2.0, regulates pH 7.0 ~ 7.2.
Above-mentioned seed culture medium composition (%): glucose 2.0, corn steep liquor 0.5, dipotassium hydrogen phosphate 0.3, potassium primary phosphate 0.1, manganous sulfate 0.005, regulates pH 6.8 ~ 7.0.
Above-mentioned fermention medium composition (%): glucose 14.0, corn steep liquor 2.0, ammonium sulfate 1.0, phosphorus ammonium 0.4, manganous sulfate 0.01, regulates pH 6.8 ~ 7.0.
embodiment 3
Above-mentioned mutagenic obtained subtilis transketolase deficient mutant strain BAV20120416 is inoculated on the slant medium of eggplant bottle, cultivates 2 days for 37 DEG C, obtained large slant strains.Bacterial classification under aseptic washing is added in eggplant bottle, make bacteria suspension, by this bacterial suspension inoculation in the 5L shaking flask that 800mL seed culture medium is housed, at 37 DEG C, rotating speed 150r/min shaking table cultivates 16 hours, and the inoculum size by 10% accesses in preprepared fermention medium, 50L fermentor tank liquid amount 30L, carry out ventilation stir culture at 37 DEG C, wherein stirring velocity is 200 ~ 300r/min, and air flow is 1 ~ 2Nm
3/ h, tank internal pressure 0.05Mpa, initial pH6.5 ~ 7.2 of fermented liquid, add soda acid by stream in fermenting process and make fermented liquid pH control 5.4 ~ 7.0, and in fermenting process, timing sampling measures the concentration of glucose and D-ribose in fermented liquid.Ferment after 49 hours, in fermented liquid, glucose content drops to 0, fermentation ends, measures D-ribose concentration 94.5 g/L; And its parental plant is under the same conditions, fermentation time 74 hours, and in fermented liquid, glucose content no longer declines after dropping to 6 g/L, D-ribose content is only 33.5g/L.
Above-mentioned slant medium composition (%): peptone 1.0, corn steep liquor 0.5, yeast powder 0.5, sodium-chlor 0.5, manganous sulfate 0.005, agar 2.0, regulates pH 7.0 ~ 7.2.
Above-mentioned seed culture medium composition (%): glucose 2.0, corn steep liquor 0.5, dipotassium hydrogen phosphate 0.3, potassium primary phosphate 0.1, manganous sulfate 0.005, regulates pH 6.8 ~ 7.0.
Above-mentioned fermention medium composition (%): glucose 18.0, corn steep liquor 2.0, ammonium sulfate 1.0, phosphorus ammonium 0.4, manganous sulfate 0.01, regulates pH 6.8 ~ 7.0.
Claims (5)
1. a subtilis (
bacillussubtilis) BAV20120416 bacterial strain, on April 16th, 2012 in the center preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms, preserving number is: CGMCC NO.6013.
2. an application rights require subtilis described in 1 (
bacillussubtilis) method of BAV20120416 fermentative production D-ribose, it is characterized in that by slant culture, seed culture and fermentation culture, produce D-ribose; Described slant medium composition % is: peptone 0.5 ~ 2.0, corn steep liquor 0.5 ~ 1.0, yeast powder 0.5 ~ 1.0, sodium-chlor 0.2 ~ 0.5, manganous sulfate 0.005 ~ 0.01, and agar 1.2 ~ 2.0, regulates pH 6.5 ~ 7.2; Described seed culture medium composition % is: glucose 1.0 ~ 3.0, corn steep liquor 0.5 ~ 1.0, dipotassium hydrogen phosphate 0.2 ~ 0.5, potassium primary phosphate 0.05 ~ 0.2, and manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2; Described fermention medium composition % is: glucose 12.0 ~ 20.0, corn steep liquor 1.0 ~ 3.0, ammonium sulfate 0.3 ~ 1.0, and phosphorus ammonium 0.2 ~ 1.0, manganous sulfate 0.005 ~ 0.02, regulates pH 6.5 ~ 7.2.
3. the method for subtilis BAV20120416 fermentative production D-ribose as claimed in claim 2, it is characterized in that the operational condition of described slant culture is: bacillus subtilis bacterial strain BAV20120416 is inoculated in slant medium, cultivate 1 ~ 2 day for 32 ~ 38 DEG C, obtained slant strains.
4. the method for subtilis BAV20120416 fermentative production D-ribose as claimed in claim 2, it is characterized in that the operational condition of described seed culture is: get slant strains and be inoculated in seed culture medium 32 ~ 38 DEG C of shaking tables cultivation 12 ~ 16h, obtained fermentation kind of a daughter bacteria liquid.
5. the method for subtilis BAV20120416 fermentative production D-ribose as claimed in claim 2, it is characterized in that the operational condition of described fermentation culture is: access in preprepared fermention medium by the inoculum size of 5 ~ 10 volume % by seed liquor, fermentation culture is carried out under 32 ~ 38 DEG C of conditions, fermentation time 40 ~ 60h, the initial pH 6.5 ~ 7.2 of fermented liquid, adding soda acid by stream in fermenting process makes fermented liquid pH control 5.6 ~ 7.0, timing sampling in fermenting process, observe growth state, measure the concentration of glucose and D-ribose in fermented liquid, when in fermented liquid, glucose concn drops to 0, maintain for some time, when D-ribose concentration no longer rises, fermentation ends.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210505600.4A CN103146595B (en) | 2012-12-03 | 2012-12-03 | Bacillus subtilis and method for fermentation production of D- ribose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210505600.4A CN103146595B (en) | 2012-12-03 | 2012-12-03 | Bacillus subtilis and method for fermentation production of D- ribose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103146595A CN103146595A (en) | 2013-06-12 |
| CN103146595B true CN103146595B (en) | 2015-02-11 |
Family
ID=48544918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210505600.4A Active CN103146595B (en) | 2012-12-03 | 2012-12-03 | Bacillus subtilis and method for fermentation production of D- ribose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103146595B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104450544B (en) * | 2013-09-17 | 2018-10-02 | 北京有色金属研究总院 | A kind of method of heavy metal ion in bacillus and its removal beneficiation wastewater |
| CN106636251B (en) * | 2016-12-16 | 2020-03-27 | 山东省食品发酵工业研究设计院 | Method for high yield of D-ribose by using bacillus subtilis engineering bacteria |
| CN106399218A (en) * | 2016-12-16 | 2017-02-15 | 山东省食品发酵工业研究设计院 | Bacillus subtilis engineering bacteria and application thereof |
| CN113142542A (en) * | 2021-02-25 | 2021-07-23 | 仇俊鹏 | Fermented seasoning sauce using grains as raw materials, preparation method and application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101338331A (en) * | 2008-07-29 | 2009-01-07 | 华东理工大学 | Method for producing D-ribose by fermenting bacillus subtilis |
-
2012
- 2012-12-03 CN CN201210505600.4A patent/CN103146595B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101338331A (en) * | 2008-07-29 | 2009-01-07 | 华东理工大学 | Method for producing D-ribose by fermenting bacillus subtilis |
Non-Patent Citations (1)
| Title |
|---|
| Production of D-ribose by fermentation.;P.De Wulf and E.J.Vandamme.;《Appl.Microbiol Biotechnol.》;19971231;第48卷;摘要，表1，143页右栏2-4段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103146595A (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100451099C (en) | Selenium-rich saccharomyces cerevisiae, selenium-rich yeast product and their production process | |
| CN100410364C (en) | Gamma-polyglutamic acid generating bacterium and process of preparing gamma-polyglutamic acid therewith | |
| CN104342390B (en) | A kind of Sinorhizobium meliloti strain and combinations thereof and application | |
| CN100485027C (en) | Method for producing D-lactic acid and spore lactobacillus special for the same | |
| CN103409485A (en) | Method for improving adenosine fermentation output through feeding organic nitrogen source | |
| CN103451137B (en) | A kind of method of new Halomonas and production tetrahydropyrimidine thereof | |
| CN1940078B (en) | Production of biological antiseptic agent phenyllactic acid | |
| CN103146595B (en) | Bacillus subtilis and method for fermentation production of D- ribose | |
| CN101078006A (en) | Bacillus pumilus capable of highly producing tetramethylpyrazine | |
| CN110791462B (en) | Bacillus subtilis and application thereof in fermentation production of adenosine | |
| CN101113410B (en) | Mortierella alpina and application thereof | |
| CN104277989B (en) | One plant of Saccharomyces cerevisiae and its application in fermenting and producing DPN | |
| CN100463961C (en) | Chromium-rich saccharomyces cerevisiae, chromium-rich yeast product and their production process | |
| CN103409486A (en) | Method for improving adenosine fermentation output through feeding hypoxanthine | |
| CN101457250B (en) | Method for synthesizing betulic acid from betulin through microbial cell bioconversion | |
| CN103571779A (en) | Fermentation medium, bacterial strain and production method for fermentation production of adenosine cyclophosphate | |
| CN100526470C (en) | Preparation method of functional sweetener D-tatai sugar | |
| CN100390295C (en) | Microorganism polysaccharide and its preparation method and application | |
| CN1141377C (en) | High-content mycose saccharomycetes and its preparing process | |
| CN109456898A (en) | A kind of the fermentation preparation and its application of chaetomium globosum dextranase | |
| CN110878260B (en) | Strain for producing D-arabitol and application thereof | |
| CN103173398B (en) | Short bacillus and method for preparing trehalose by virtue of fermentation | |
| JPH07246097A (en) | Method for producing trehalose | |
| CN1170925C (en) | Fermentation production process of alkaline mycose lyase and microbe for producing the lyase | |
| CN1053697C (en) | Fermentation method for producing D-ribose novel strain, and method for prepn. of D-ribose using said strain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BINZHOU COLLEGE Effective date: 20150130 Owner name: SHANDONG JINLANG BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHANDONG BANG'AO ENTREPRENEURIAL BIOTECHNOLOGY CO., LTD. Effective date: 20150130 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Jingguang Inventor after: Wang Caifeng Inventor after: Li Xiaoyun Inventor before: Cai Huiying |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CAI HUIYING TO: WANG JINGGUANG WANG CAIFENG LI XIAOYUN |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150130 Address after: 256660 No. five, No. 208, hi tech Industrial Development Zone, Shandong, Binzhou Patentee after: SHANDONG JINLANG BIOTECHNOLOGY Co.,Ltd. Patentee after: BINZHOU University Address before: 256660 No. five, No. 208, Binzhou hi tech Industrial Development Zone, Shandong, Binzhou, China Patentee before: SHANDONG BANGAO ENTREPRENEURIAL BIOTECHNOLOGY Co.,Ltd. |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: No. 208, gaowu Road, high tech Zone, Binzhou City, Shandong Province Patentee after: Shandong Weiyan Biotechnology Co.,Ltd. Patentee after: BINZHOU University Address before: 256660 No. 208, gaowu Road, Binzhou high tech Industrial Development Zone, Shandong Province Patentee before: SHANDONG JINLANG BIOTECHNOLOGY Co.,Ltd. Patentee before: BINZHOU University |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20210803 Address after: 256399 No.1, Jinyang Road, Gaoqing Economic Development Zone, Zibo City, Shandong Province Patentee after: SHANDONG JINYANG PHARMACEUTICAL Co.,Ltd. Patentee after: BINZHOU University Address before: No. 208, gaowu Road, high tech Zone, Binzhou City, Shandong Province Patentee before: Shandong Weiyan Biotechnology Co.,Ltd. Patentee before: BINZHOU University |
|
| TR01 | Transfer of patent right |